Ocugen, Inc.

NASDAQ:OCGN

Biotechnology

Healthcare
$0.76 +2.46%

+$0.03 today

Market cap
$256.75M
Beta
2.21
P/E (TTM)
-5.6
EPS (TTM)
-$0.22
52W Low $0.90High $2.73

Volume 5.47M

Average 7.51M

Income Statement

Follow revenue through to earnings.

Revenue

$4.41M

FY 2025 · Annual

+8.8% YoY

Operating Income

-$62.92M

FY 2025 · Annual

Net Income

-$67.85M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue02.49M6.04M4.06M4.41M
Cost of Revenue00704K1.97M2.39M
Gross Profit02.49M5.33M2.09M2.02M
Gross Margin—100.0%88.3%51.5%45.9%
Research & Development35.11M56.16M39.57M32.13M39.75M
Selling, General & Admin22.92M35.4M31.99M26.69M27.58M
Operating Expenses58.03M91.56M70.86M56.84M64.94M
Depreciation & Amortization229K480K704K1.97M2.39M
EBITDA(58.11M)(86.32M)(62.37M)(52.09M)(60.27M)
EBITDA Margin—-3469.6%-1033.4%-1284.5%-1365.7%
Operating Income(58.03M)(89.07M)(65.53M)(54.76M)(62.92M)
Operating Margin—-3580.0%-1085.7%-1350.4%-1425.7%
Interest Income01.4M2.5M1.3M922K
Interest Expense79K0005.19M
Other Income / Expenses(389K)2.27M2.45M703K(4.93M)
Income Before Tax(58.42M)(86.8M)(63.08M)(54.05M)(67.85M)
Pre-Tax Margin—-3488.9%-1045.0%-1333.0%-1537.4%
Income Tax Expense(52K)0000
Net Income(58.37M)(86.8M)(63.08M)(54.05M)(67.85M)
Net Margin—-3488.9%-1045.0%-1333.0%-1537.4%
EPS (Basic)(0.30)(0.40)(0.26)(0.20)(0.23)
EPS (Diluted)(0.30)(0.40)(0.26)(0.20)(0.23)
Weighted Avg Shares195.01M214.6M244.33M271M300.17M
Weighted Avg Shares (Diluted)195.01M214.6M244.33M271M300.17M

OCGN Earnings Waterfall · TTM

NASDAQ:OCGN · Revenue to Net Income

Key Ratios

EPS$-0.23
Gross Margin100.0%
Net Margin1426.3%
P/E Ratio-6.1
P/S Ratio-329.3

Analysis

$4.5M of revenue converted into -$71.7M of net income for the selected period. Gross margin is 100.0% and net margin is 1426.3%, showing how much revenue survives after costs and taxes. EPS is $-0.23, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 10, 2026
DEFA14ADEFA14A filingNov 6, 2026
DEFA14ADEFA14A filingNov 6, 2026
10-QQuarterly reportNov 4, 2026
8-KCurrent reportNov 4, 2026

How much revenue does OCGN generate?

Ocugen, Inc. (OCGN) reported $4.41M of revenue in fiscal 2025.

Is OCGN profitable?

Ocugen, Inc. (OCGN) reported -$67.85M of net income, with a net margin of -1537.4%.